Perez, Jocelyn D.
HRN: 24-70-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
04/10/2024
04/16/2024
IVTT
500 Mg
OD
Sepsis, Cap Hr, Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes